Navigation Links
Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Date:12/8/2011

ielding 43 million reads per each duplexed sample, 69 percent of which uniquely map to the human genome.  Standardized hazard ratios and p-values for the 21 Oncotype DX genes determined by RNA-Seq were comparable to those originally obtained using RT-PCR.  Additionally, whole transcriptome RNA-Seq revealed more than 1,800 new coding and non-coding RNAs associated with breast cancer recurrence risk, many of which belong to previously unrecognized gene networks. Additional research will be performed to determine whether these new genes can be observed in other cohorts and whether they add value beyond the 21 Oncotype DX genes.

The study, "Breast Cancer Recurrence Risk Probed by Whole Transcriptome Next-Generation Sequencing in 136 Patients," is presented on Thursday, December 8 at 7:00 a.m. CT.

About Genomic Health and the Oncotype DX® Tests
Genomic Health, Inc. (NASDAQ: GHDX) is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions.

Its lead product, the Oncotype DX Breast Cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer to help optimize treatment options.  Oncotype DX is the only test incorporated in published ASCO® and NCCN® breast cancer treatment guidelines for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive.(1)  The test is also recognized in international guidelines issued by St. Gallen International Breast Cancer Expert Panel and European Society for Medical On
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Personalized Medicine - The Genomic Revolution in Cardiac Care
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015  Leadership speaker and business author Mary Kelly, Ph.D ., is helping members ... Photo - http://photos.prnewswire.com/prnh/20150420/199849 ... ... ... possible to run a successful medical practice without pulling your hair out of your head or ...
(Date:4/21/2015)... 21, 2015  The increase of diabetes due ... for self-monitoring blood glucose (SMBG) meters and strips ... potential for this market.  Availability of inexpensive generic ... profit margins. Photo - http://photos.prnewswire.com/prnh/20150417/199443 ... & Sullivan, US Self-monitoring Blood Glucose Market ...
(Date:4/21/2015)... April 21, 2015  GenVec, Inc. (NASDAQ: ... a research collaboration agreement with the Laboratory of ... Institute of Allergy and Infectious Diseases, National Institutes ... will utilize GenVec,s proprietary gorilla adenovirus vectors to ... the LMIV in order to create and test ...
Breaking Medicine Technology:Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 2Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 3Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 4Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 5Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 2Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 3Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 4GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology 2GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology 3
... acute coronary syndrome being managed with percutaneous coronary ... ... Feb. 21 Daiichi,Sankyo Company, Limited (TSE: 4568) and Eli Lilly ... and Drug Administration (FDA) accepted,and designated Priority Review for the New ...
... Rx, a drug delivery,company specializing in dissolving thin ... completed a pilot clinical study for its,thin film ... in the prevention and treatment of nausea and ... ondansetron was studied against,GlaxoSmithKline,s Zofran ODT(R) product. Based ...
Cached Medicine Technology:FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel 2FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel 3MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study 2MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study 3
(Date:4/21/2015)... Zane Benefits, the leader in individual ... publication of a new guide “Health Reimbursement Accounts in ... the health insurance industry, including how employers can use ... what is permitted when implementing an HRA. This simple, ... which HRAs are compliant this year. , According ...
(Date:4/21/2015)... 2015 Autocarsinsurancetips.com has released a new ... auto insurance plans by comparing quotes. , ... the best policies in their neighborhood. The insurance market ... best offer simply by comparing different plans. , ... car insurance quotes. Insurance brokerage websites like http://autocarsinsurancetips.com/ ...
(Date:4/21/2015)... has released a new blog post explaining the importance of ... on a uto insurance prices . , Drivers ... for advantageous auto insurance discounts. Clients can now review multiple ... will also help them get the best rates in their ... cost coverage is no longer difficult as there are multiple ...
(Date:4/21/2015)... LifeWings Partners LLC today announced a toolkit to ... safety programs by getting more support from their physicians. ... ways to get more physician support and engagement in ... Act, the new model of health care reimbursement is ... volume of services. Health care leaders feel an increased ...
(Date:4/21/2015)... April 21, 2015 When a bandage ... can result. In order to solve this problem two ... Bandaging. , This improved bandage helps a cut, burn, ... pain and enhances air exposure. The bandage is easy ... The original design was submitted to the St. Louis ...
Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes Can Help Clients Save Money 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:LifeWings Announces New Physician Engagement Toolkit to Help Hospitals Weather Serious Ramifications of the Affordable Care Act 2
... Legislation passed today by the Democratically-controlled Michigan House ... the pockets of personal injury lawyers at the ... of Commerce."By repealing Michigan,s lawsuit abuse protections, the ... Michigan becomes a lawsuit magnet," said Wendy Block, ...
... real-time communication tools like instant messenger, texts and mobile ... engage with physicians."A lot of people at our company ... sales executive in a roundtable discussion conducted by Best ... distracted by doing four things at once that the ...
... or chasing a cat causes many tumbles, CDC reports, , , ... be favored companions of many Americans, but they,re also apparently ... each year. , U.S. health officials report that 86,629 people ... people a day who wind up in hospital emergency rooms, ...
... Bill Puts Patient Health and Safety and ... The Generic Pharmaceutical Association (GPhA) released ... and CEO Kathleen Jaeger regarding the bipartisan ... Access to Life-Saving Medicine Act.""Momentum is skyrocketing ...
... used bacteria to strip the drink of carbs , , ... say they,ve developed a low-calorie, low-sugar vegetable juice for ... said it uses lactic acid-producing bacteria (LAB) to remove ... other nutrients. LAB, also known as probiotics, are used ...
... Three researchers at the Johns Hopkins University School of Medicine ... Medical Institute (HHMI). Xinzhong Dong, Ph.D., Joshua Mendell, M.D., Ph.D., ... but also become employees of HHMI, which will provide research ... "We are thrilled for Xinzhong, Josh and Sin for being ...
Cached Medicine News:Health News:Sales Force Effectiveness: Less Texting, More Engagement 2Health News:For All Their Plusses, Pets Pose a Risk for Falls, Too 2Health News:For All Their Plusses, Pets Pose a Risk for Falls, Too 3Health News:GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act' 2Health News:Three Johns Hopkins researchers named Howard Hughes Medical Institute early career scientists 2
For the quantitative determination of triglycerides in serum. Linearity: 1000 mg/dl....
Alkaline phosphatase FS (IFCC). For determination of alkaline phosphatase (ALP) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
For the quantitative determination of alkaline phosphatase in human serum....
Intended for the quantitative determination of alkaline phosphatase activity in serum or plasma. Kinetic reaction. 405 nm wavelength. 830 U/L at 30C linearity. Single vial, dry powder reagent....
Medicine Products: